症状到气球时间对非ST段升高心肌梗塞和复杂病变的患者的影响
Yong Hoon Kim1, Ae-Young Her1, Seung-Woon Rha2
1Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon.
Journal of cardiovascular medicine (Hagerstown, Md.)
|October 24, 2024
概括
将症状到气球时间 (SBT) 缩短到48小时以下,可显著降低非ST升高心肌梗塞 (NSTEMI) 患者的3年死亡率,特别是那些患有复杂病变的患者. 这有助于改善NSTEMI护理的结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 临床结果研究研究
背景情况:
- 对于非ST升高心肌梗塞 (NSTEMI) 患者,临床结局数据有限.
- 穿皮冠状动脉干预 (PCI) 使用新一代药物排泄支架是NSTEMI的常见治疗方法.
- 根据病变复杂性和症状到气球时间 (SBT) 的分层对理解NSTEMI结果至关重要.
研究的目的:
- 为了比较NSTEMI患者接受PCI的临床结果,用药物排泄支架进行PCI.
- 评估复杂病变和SBT (<48小时 vs ≥48小时) 对NSTEMI患者结局的影响.
- 确定最佳的治疗策略,以改善NSTEMI的生存率和减少不良事件.
主要方法:
- 来自韩国急性心肌梗塞登记-国家卫生研究院的4373名NSTEMI患者的分析.
- 基于病变特征和SBT的复杂 (n=2106) 和非复杂 (n=2267) 群体的分层.
- 主要终点:三年全因死亡率;次要终点:主要心脏不良事件 (MACE),心脏死亡,心肌梗塞复发和中风.
主要成果:
- 在复杂组中,SBT <48小时与明显较低的全因死亡率,心脏死亡率和MACE相关.
- 与SBT≥48小时患者相比,SBT<48小时患者的死亡率和MACE较低,无论病变复杂程度如何.
- 在复杂组中,较短的SBT (<48小时) 降低了死亡率和MACE,而非复杂组中较短的SBT中,中风发生率更高.
结论:
- 将症状到气球的时间缩短到48小时以下是减少NSTEMI患者3年死亡率的有效策略,特别是那些患有复杂病变的患者.
- 较短的SBT改善了整体结果,并在接受PCI的NSTEMI患者中减少了MACE.
- 及时干预对于管理NSTEMI和改善患者预后至关重要.
相关概念视频
01:30Acute Coronary SyndromeI: Introduction
3
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
01:30Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
01:28Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
01:19Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
3
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
3
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103